Question 1

Importance of 9-Valent Vaccine

Accepted Answer

Protects against 7 oncogenic high-risk strains (16, 18, 31, 33, 45, 52, 58). Prevents 2 low-risk strains causing genital warts (6, 11). Significantly reduces the risk of cervical, vaginal, and anal cancers.

Question 2

Target Groups

Accepted Answer

Girls and women for cervical cancer prevention. Boys and men to prevent warts and HPV-related cancers. Children and adolescents starting from age 9 for optimal immune response.

Question 3

Dosage Schedule

Accepted Answer

Two doses for those starting the series before age 15. Three doses for those starting the series at age 15 or older. The physician determines the schedule based on age and health status.

Comprehensive Cervical Cancer Protection - 9-Valent Human Papillomavirus (HPV) Vaccination Program